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 DEBATE: THIS HOUSE BELIEVES THAT NORMAL 
STRUCTURES DELINEATIONS SHOULD BE DELEGATED 
TO RTTS?  
  
SP-0302  For the motion  
M.E. Mast1 
1Radiotherapy Centre West, Radiotherapy, The Hague, The 
Netherlands  
  
With the increasing age of the European population, the number of 
cancer patients will increase further in the coming decades. Besides 
surgery and systemic therapy, radiation therapy is an important part 
of the primary (and palliative) treatment in many tumour sites. The 
radiation oncologist is spending more and more time on the multi-
disciplinary approach of the cancer patient. Furthermore, preparing 
modern radiotherapy is becoming more time consuming for the 
radiation oncologist.  
And, among others, organs at risk have to be delineated. Because, in 
doing so, the dose to the OAR can be kept low resulting in a lower 
probability of radiation induced side effects.  Also, highly conformal 
techniques and hypofractionation schemes become the current 
practice and, a precise delineation of the OARS becomes even more 
important. Automatic delineation programs exist and can be helpful to 
perform a standardized OAR delineation to guide the RTT to an 
optimal delineation of OAR. Proper training is necessary to distinguish 
between normal tissue and tumour extension. The RTT is more and 
more involved in the treatment planning process and delineating the 
OARs overlap for several tumoursites. In the training of the RTTs the 
delineation on MRI on PET-CT should be included as well, it appeared 
that for some tumoursites the OARs can be visualised better on those 
imaging modalities. 
Finally, when the guidelines for delineation of the OARs are defined 
precisely, we can move over to another level in the delineation of 
structures. Radiation therapists might perform the delineation of the 
CTV of some tumour sites, to increase the departmental efficiency 
and to decrease the interobserver variability of delineating the CTVs. 
Batumulai et al. stated that the interobserver variability between 
radiation oncologists and radiation therapists was low, and their study 
provided support in CTVBreast delineation by the radiation therapists 
based on a standardized protocol [Batumulai et al, 2011]. 
Conclusion: To avoid a delay in the treatment and to increase the 
level of uniformity, delineation of the OARs by properly trained 
radiation therapists is the next step in the process of preparing an 
optimal radiation treatment. 
Reference: Batumulai V, Koh ES, Delaney GP, et al. Interobserver 
variability in Clinical Target Volume delineation in tangential breast 
irradiation: a comparison between radiation oncologists and radiation 
therapists. Clinical Oncology 2011; 23: 108-113. 
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Against the motion 
F. Moura1 
1Hospital Cuf Descobertas, Department of Radiotherapy, Lisboa, 
Portugal  
 
The perspective of changing the paradigm, from 2D unclear volumes 
and surrounding tissues to 3D/4D morphological and functional 
imaging information, clear and unambigous OARs delineation, take a 
pivotal importance when highly conformal techniques and 
hypofractionation schemes become the current practice. 
Against the motion, arguments will focus on: medical issues, legal 
aspects and policies; educational curricula, basic/advanced education 
and training; continuous professional development with the gain of 
specific knowledge, skills and competences; role development and 
professional recognition. 
The scientific debate will highlight relevant aspects, related to the 
delineation of OARs in QUANTEC era; dose response relationships; 
dose volumes constraints and endpoints; radiobiologic NTCP models; 
imaging for volumes delineation and interobserver variability. 
 
 SYMPOSIUM: REGENERATIVE THERAPY  
  
SP-0304   
When and how is regenerative therapy an option after radiotherapy  
R.P. Coppes1 
1University of Groningen University Medical Center Groningen, 
Departments of Radiation Oncology and Cell Biology, Groningen, The 
Netherlands  
 
Normal tissue damage after radiotherapy may cause severe, life 
threatening complications that may even interfere with the dose that 
can be applied to the tumour. Normally tissues respond to damage by 
activating stem and/or progenitor cells, which multiply by asymmetric 
division to form stemcells and newly differentiated cells. After 
irradiation this response may be affected due to the lethal amount of 
DNA damage and/or to a changed environment, which inhibits the 
remaining stem/progenitor cells to exert there regenerative potential. 
Regenerative therapy can be used to rejuvenate the tissues 
stem/progenitor cells or stimulate remaining stem cells to re-establish 
homeostasis.  
Preclinical studies will be discussed that have shown that remaining 
stem cells can be stimulated to enhance regeneration inirradiated 
tissue by the application of growth factors and bone marrow derived 
cells. These therapies however only have therapeutic potential when 
sufficientstem/progenitor cells have survived the radiation insult. If 
not, stem cell therapy could be an option. The use of embryonic stem 
cells or induced pluripotent stem cells (iPS), however is still in its 
infancies. Therefore, adult stem cell therapy is preferable in the near 
future. For patients receiving radiotherapy, collection of tissue stem 
cells before cancer treatmentseems feasible. As such bone marrow 
transplantation has been used for many years re-establish the 
haematopoiesis. For several organs adult stem cells have now been 
isolated and characterized. Recent developments in the use of adult 
stem cells therapies will be discussed in relation to their potential use 
after radiotherapy. 
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Haematopoietic stem cells and radiation 
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1CEA - Université Paris Diderot - Paris 7, Département des Sciences du 
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The paradigm of DNA damage and mutagenesis has been a driving 
force for understanding the biological and health consequences of 
ionizing radiation (IR) and, among the cellular target cells of IR, 
somatic stem cells are of particular interest. Somatic stem cells can 
self-renew and can produce numerous types of mature effector cells 
throughout life and thus, accumulating genetic alterations after 
irradiation can compromise their genomic integrity and may 
potentially give rise to cancer. Adult hematopoiesis, one of the best-
studied models to understand the biology of adult stem cells in vivo 
and in vitro, is a hierarchic process in which immature hematopoietic 
progenitors undergo progressive changes, including proliferation and 
differentiation steps that finally lead to the production of mature 
cells. The hematopoietic hierarchy can be declined into four main 
compartments: stem cells (HSCs), immature progenitors, precursors 
and mature cells. Long-term-HSCs (LT-HSCs) are the most immature 
population in the hematopoietic system. They are rare and mostly 
quiescent and, in response to extrinsic/intrinsic signals, they self-
renew and/or give rise to short-term-HSC (ST-HSCs). ST-HSCs are less 
quiescent and have limited self-renewal compared to LT-HSCs. They 
can give rise to multipotent progenitors (MPP), which undergo 
multiple rounds of division to produce the various immature 
progenitors that can differentiate into mature hematopoietic cells. 
Compared to hematopoietic progenitors, hematopoietic stemcells 
(HSCs) are more resistant to IR when exposed to doses ranging from 
1Gy to 4Gy, however this resistance is associated with genomic 
instability in HSCs, asHSCs repair DNA damages by the non-homologous 
end joining (NHEJ), an error-prone mechanism. In contrast to the 
effects of high doses of IR, the effects of low doses on hematopoietic 
stem cells have not been extensively studied. 
We have determined if low doses of irradiation could have an impact 
on hematopoietic stem cells (HSCs) function. An enriched HSCs 
population was irradiated at 0.02Gy 0.1Gy, 0.25Gy or at 2.5Gy and the 
irradiated cells were transplanted into a lethally irradiated recipient 
mice.Six months after primary transplantation the only compartment 
affected was the HSCs compartment with a reduction of LT-HSCs pool 
for doses as low as 0.1Gy.The bone marrow of those mice were 
transplanted into secondary recipient mice and we found that LT-HSCs 
reconstitution capacity was decreased from 0.02Gy, showing defectual 
self-renewal. Finally, treatment of the mice with 5-FU showed that 
mice that have received irradiated HSCs at doses as low as 0.02Gy 
died prematurely compared to mice transplantated with non-
irradiated HSCs. Thus, doses as low as 0.02Gy can drive multiple 
defects in HSCs, affecting their function in the long-term. We will 
discuss these results and show data on the molecular basis of this HSCs 
sensitivity to low doses of irradiation. 
   
 
